DeutschNewstral
Article
Mmarketwatch.com on 2019-07-29 18:11
Wall Street is not exactly impressed with the Pfizer-Mylan deal
Related news
- MWall Street thought Mylan was headed for disaster—now, analysts are ravingmarketwatch.com
- HTeva Shares Up on Mylan-Pfizer Mergerhamodia.com
Spinoff of Pfizer will join Mylannwaonline.com
Wall Street Not Impressed by Latest Apple Eventbreitbart.com
Wall Street not impressed by U.S. Bancorp's fourth quarterbizjournals.com- ATwitter is profitable again in 1Q, Wall Street not impressedapnewsarchive.com
- BFord's EV Plan Impressed Wall Street. Analysts Are Weighing In.barrons.com
- BBeyond Meat Stock Is Soaring. Wall Street Isn’t Impressed.barrons.com
Pfizer profit plunges 38 per cent, misses Wall Street expectationsThe Globe and Mail- BSquare Is Joining Forces With Jay-Z in Music Streaming. Wall Street Isn't Impressed.barrons.com
Bernie Sanders Is Really Not Impressed With Hillary Clinton's Plan For Wall Streethuffingtonpost.com- BFortinet Earnings Impressed Wall Street. Analysts Say Buy the Stock Now.2 min readbarrons.com
Twitter Co-Founder Ev Williams Not Impressed By Wall Street. Not At All.VOX recode- BFacebook's Earnings Beat Forecasts. Why Wall Street Wasn't Impressed.3 min readbarrons.com
Week Ahead On Wall Street: Fed Takes Center Stage, Mylan CEO To Testify On EpiPen Price HikeForbes
Pfizer, Mylan strengthen ties, create new companyabqjournal.com- HPfizer to Absorb Mylan, Creating Generic Gianthamodia.com
Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecastSeattle Times
Pfizer posts big 2Q profit jump, announces deal with Mylanreviewtimes.com